Academic Panel of Scientists to Meet With FDA Regarding Avandia Risks

On Monday, July 30, a panel of academic scientists will meeting with the Food and Drug Administration to discuss how regulators should respond to the accusation that the diabetes drug Avandia, made by GlaxoSmithKline, increases the risk for heart attacks in users.

In may, a published paper shocked patients and the medical community alike with the statement that Avandia increases the risk of heart attacks in users by 40 percent.

The panel that is to convene will seek to weigh whether Avandia is safe, doing so by analyzing all the data available.

If you or a loved one has suffered cardiac complications after ingesting Avandia, you deserve the guidance of a knowledgeable drug attorney. Get a free case review by filling out the form below.

Click To Talk To Us Online

Study, 7.12.07

Latest News on Avandia: German Study Adds More Reasons to Avoid it
Latest Study in the News: Avandia May Worsen Complications of Diabetes

Sales Plunge

Report: Avandia's Sales Plunge After Study Raises Safety Concerns
Study Suggested Avandia Had Safety Concerns, Raised Heart Attack Risk

News & Warnings

Avandia News and Information | Weitz & Luxenberg
Bloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001

Name

Phone

strictly confidential

Your Question

Contact Name
Email Address
Phone Number
When did you start taking Avandia?
Did you experience cardiovascular problems after taking Avandia?
What was the date you experienced cardiac complications?
Did you have any cardiovascular disease before taking Avandia?
Did you suffer a bone fracture after taking either Avandia or Actos?
Please provide detail about your bone fracture injury, including the date of the injury, how the fracture occured and what bone(s) were affected.
Additional information